What Has Happened to the Filler You Injected?

If you had filler injected five or more years ago, you probably assumed it is long gone. Perhaps you have noticed gradual changes in your facial contour that you attributed to aging. Perhaps new lumps have appeared in areas that were treated years ago. You may be wondering whether old filler could still be involved — and the answer, more often than patients expect, is yes.

If you were to undergo a high-resolution ultrasound scan today, you might be surprised to discover that many of those fillers that "should have disappeared" are still present in your tissue — only their form has changed dramatically from the day they were injected.

Key Insight: At FILLER REVISION, our clinical experience confirms that the fate of fillers inside the body is far more complex than what product labels describe. "Absorbable" does not mean "completely gone," and "duration of 12–18 months" does not mean the filler drops to zero after 18 months. Understanding these long-term changes is the first step toward making informed repair decisions.

The Basic Science of Filler Degradation

Three Pathways of In Vivo Degradation

All fillers injected into tissue face three major degradation pathways, as documented in comprehensive histological studies of injectable filler persistence (Lemperle et al., 2003):

• Enzymatic degradation: Specific enzymes in the body — such as hyaluronidase — can break down certain filler materials. This is the primary degradation pathway for hyaluronic acid, but cross-linked structures significantly slow the process.

• Hydrolysis: Tissue fluid gradually infiltrates the chemical structure of the filler, breaking molecular chains. This is the primary degradation pathway for PCL (polycaprolactone) and PLLA (poly-L-lactic acid), typically measured in years.

• Cell-mediated degradation: Macrophages and foreign body giant cells attempt to engulf and break down filler fragments. This process occurs with all fillers but varies greatly in efficiency depending on material properties.

Factors Influencing Degradation Speed

Factor | Accelerates Degradation | Slows Degradation

:---: | :---: | :---:

Cross-linking degree | Low cross-linking | High cross-linking

Injection site mobility | High-movement areas (lips, nasolabial folds) | Low-movement areas (temples, forehead)

Local blood circulation | Rich blood supply | Limited blood supply

Injection volume | Small amounts | Large boluses

Immune response intensity | Strong response | Mild response

Degree of encapsulation | Not encapsulated | Fully encapsulated

The 5–10 Year Fate of Different Filler Types

Hyaluronic Acid (HA): The Truth About "Absorbable"

HA is marketed as an "absorbable, safe, short-acting" filler, with labeled durations typically between 6 and 18 months. However, clinical and imaging evidence tells a different story.

During the first 1–2 years, the filler does degrade — but primarily the non-cross-linked or lightly cross-linked portions. The visible volume effect gradually diminishes, and patients believe "the filler has been absorbed." But the highly cross-linked core structure often persists.

Remaining highly cross-linked HA fragments continue to degrade slowly, but the rate has decreased markedly. Meanwhile, these fragments may:

• Become encased in fibrous tissue, forming capsular structures

• Gradually migrate downward due to gravity and muscle activity

• Absorb surrounding water, maintaining a certain volume

• Trigger a low-grade chronic inflammatory response

On ultrasound, HA injected 5–10 years ago can frequently be detected — as small residual clusters, scattered fragments, or encapsulated nodules. These residues may not cause obvious aesthetic issues, but they are there, and they may interact with new filler if re-injection is performed.

Key Insight: Studies show that even at 2–3 times the labeled duration, a significant proportion of HA residue can be detected on MRI or ultrasound. "Absorbable" does not equal "completely absorbed." To learn more about this myth, see The Myth of Complete HA Absorption.

Poly-L-Lactic Acid (PLLA/Sculptra): The Long-Term Fate of Microspheres

PLLA is injected as microspheres designed to stimulate autologous collagen production. The microspheres themselves are expected to degrade completely within 2 years.

PLLA microspheres gradually disintegrate through hydrolysis into lactic acid molecules, which are metabolized by the body. Simultaneously, the microspheres stimulate surrounding collagen neogenesis, producing volume.

If microsphere degradation is uneven (certain areas accumulate too many microspheres), localized nodules of excessive collagen proliferation may form. The cores of these nodules may still contain incompletely degraded PLLA fragments, surrounded by dense collagen fibers.

Even if PLLA microspheres eventually degrade completely, the collagen structures they stimulated do not disappear along with them. This new collagen may persist for many years, forming permanent fibrotic structures in some cases. Learn more about lumps appearing years after injection.

Polycaprolactone (PCL/Ellanse): The Slow Journey of Microspheres

PCL microspheres degrade more slowly than PLLA, with designed durations of 1–4 years depending on the product variant.

PCL microspheres slowly degrade while stimulating collagen production. The gel carrier (CMC) is absorbed within months, but the microspheres themselves degrade over years.

Clinical experience shows that some PCL microspheres may persist beyond their designed duration. These residual microspheres may:

• Become encapsulated and remain stable

• Continue degrading at an extremely slow rate

• In certain cases, trigger delayed immune responses

Long-term follow-up data is limited, but case reports indicate that some PCL residues can be detected more than 7 years after injection. The clinical significance of these residues — whether they will cause problems — depends on individual immune responses and residual volume.

Permanent Fillers: Guests Who Never Leave

Silicone, polyacrylamide gel (PAAG), and other permanent fillers, as their name implies, are never broken down by the body. A comprehensive review of adverse reactions to injectable soft tissue fillers confirmed that permanent materials carry the highest long-term complication rates (Requena et al., 2011).

Timeline | Changes | Clinical Impact

:---: | :---: | :---:

1–3 years | Stable period, encapsulation may begin | Usually no obvious problems

3–5 years | Capsule gradually thickens, migration may begin | Mild asymmetry, hardened feel

5–10 years | Chronic inflammation, cumulative migration, capsular contracture | Shape distortion, lump formation

10–20 years | Severe migration, granulomas, tissue destruction | Significant deformity, repair surgery needed

20+ years | Deep integration with surrounding tissue | Extremely difficult to remove

What Long-Term Changes Mean for FILLER REVISION Patients

For patients considering revision after years of living with filler, these long-term changes have direct implications for treatment planning. At FILLER REVISION, we encounter patients whose filler has transformed significantly from its original state — partially degraded HA with encapsulated residues, PLLA-stimulated collagen structures that persist despite microsphere degradation, and permanent fillers that have migrated far from their injection sites. Each scenario requires a different revision strategy, and the only way to determine the current state is through imaging. An ultrasound assessment before any intervention reveals not just where the filler is, but what it has become — information that is essential for setting realistic expectations and choosing the right approach.

Long-Term Filler–Tissue Interactions

Tissue Remodeling: Your Face Adapts to the Filler

Fillers do not passively exist within tissue. Over time, surrounding tissues undergo significant remodeling:

Filler Migration: The Long-Term Effect of Gravity

• Gravity: A constant downward force

• Muscle activity: Repeated contraction of facial muscles pushes filler material

• Tissue laxity: As aging progresses, surrounding tissue's ability to anchor filler decreases

• Volume changes: Shape changes from partial filler degradation

How Ultrasound Reveals These Long-Term Changes

High-resolution ultrasound is the ideal tool for observing long-term filler changes. Fillers at different stages present distinct ultrasound characteristics:

• Fresh filler: Uniform echogenicity with clear boundaries

• Partially degraded filler: Heterogeneous echogenicity with blurred boundaries

• Encapsulated filler: Hyperechoic capsule surrounding a hypoechoic core

• Calcified filler/fat: Strong echogenicity with posterior acoustic shadowing

• Migrated filler: Filler signal appearing in unexpected locations

This radiation-free, real-time, repeatable examination allows physicians to comprehensively assess the current state of fillers. Before considering any repair or re-injection, understanding the distribution of existing fillers in the tissue is essential. See the filler repair evaluation process for details.

Key Insight: If you have had filler injections in the past 5–10 years, an ultrasound assessment before any new injection can reveal residues you may not know about — fillers that "should have disappeared" but are in fact still present in your face.

Clinical Implications: How These Long-Term Changes Affect You

Risk Assessment for Re-Injection

Understanding long-term filler changes is critical for planning re-injection:

• Cumulative effect: Repeated injections at the same site accumulate residues, and the total volume may far exceed what you imagine

• Material interactions: Different brands of fillers injected at different times may produce unpredictable interactions

• Encapsulated filler resistance to dissolvers: HA encased in capsules shows dramatically reduced response to hyaluronidase

Planning Repair Treatment

When long-term fillers cause aesthetic or functional problems, repair treatment must consider:

• The exact location and distribution of filler (which may have moved from the original injection site)

• The current state of filler (partially degraded, encapsulated, calcified)

• The degree of surrounding tissue changes

• Whether staged treatment is necessary

Ultrasound-guided minimally invasive extraction can precisely locate and remove these long-standing filler residues under real-time image guidance while maximizing preservation of the altered surrounding tissue structures.

Know What Is Still Inside — FILLER REVISION Can Show You

If your filler injections were more than 5 years ago and you currently have no discomfort, you may not need to do anything. But if you have noticed gradual shape changes, unexplained lumps, or are planning to receive filler injections again, FILLER REVISION can reveal the true state of affairs inside your tissue through ultrasound assessment. Knowing what remains — and what it has become — allows you to make decisions based on evidence rather than assumptions.